These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16043348)

  • 1. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
    Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
    Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
    Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
    Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
    J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
    Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
    BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed genes in oral squamous cell carcinoma.
    Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
    Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV; Kovacs G
    Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.
    Diegmann J; Tomiuk S; Sanjmyatav J; Junker K; Hindermann W; von Eggeling F
    Int J Mol Med; 2006 Sep; 18(3):395-403. PubMed ID: 16865223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.
    Sartini D; Muzzonigro G; Milanese G; Pierella F; Rossi V; Emanuelli M
    J Urol; 2006 Nov; 176(5):2248-54. PubMed ID: 17070307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
    Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K
    BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
    Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
    Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.